158 related articles for article (PubMed ID: 31595639)
1. Terbinafine: Safety profile and monitoring in treatment of dermatophyte infections.
Sun CW; Hsu S
Dermatol Ther; 2019 Nov; 32(6):e13111. PubMed ID: 31595639
[No Abstract] [Full Text] [Related]
2. Terbinafine-induced liver injury.
Kaushal M; Tolani P; Kumar N; Sharma S
Natl Med J India; 2017; 30(6):321-323. PubMed ID: 30117442
[TBL] [Abstract][Full Text] [Related]
3. Terbinafine-induced hepatotoxicity.
Mejías Manzano MLÁ; Giráldez Gallego Á; Ontanilla Clavijo G; Sousa Martín JM
Gastroenterol Hepatol; 2019; 42(6):394-395. PubMed ID: 31167724
[No Abstract] [Full Text] [Related]
4. An unusual photodistributed acute generalized exanthematous pustulosis induced by terbinafine.
Ladhari C; Mokni S; Fathallah N; Zariaa S; Boussofara L; Aounallah A; Sriha B; Belajouza C; Ben Salem C; Denguezli M; Nouira R
Therapie; 2019 Sep; 74(4):502-504. PubMed ID: 30955868
[No Abstract] [Full Text] [Related]
5. Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis.
Wang Y; Geizhals S; Lipner SR
J Am Acad Dermatol; 2021 Feb; 84(2):497-499. PubMed ID: 32387655
[No Abstract] [Full Text] [Related]
6. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood dermatophyte infections with oral terbinafine.
Goulden V; Goodfield MJ
Pediatr Dermatol; 1995 Mar; 12(1):53-4. PubMed ID: 7792222
[TBL] [Abstract][Full Text] [Related]
9. Concurrent terbinafine-induced acute generalised exanthematous pustulosis and hepatitis.
Carnio LR; Johnson Shaw ME; Schnur J; Casadesus D
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462036
[TBL] [Abstract][Full Text] [Related]
10. Terbinafine: an update.
Gupta AK; Shear NH
J Am Acad Dermatol; 1997 Dec; 37(6):979-88. PubMed ID: 9418768
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
[TBL] [Abstract][Full Text] [Related]
12. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
Davis R; Balfour JA
Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
[TBL] [Abstract][Full Text] [Related]
13. Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections.
Stolmeier DA; Stratman HB; McIntee TJ; Stratman EJ
JAMA Dermatol; 2018 Dec; 154(12):1409-1416. PubMed ID: 30347032
[TBL] [Abstract][Full Text] [Related]
14. A Case of Progressive Cholestatic Drug-Induced Liver Injury Due to Terbinafine.
Ley D; Musto J; Said A
WMJ; 2023 May; 122(2):138-142. PubMed ID: 37141482
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.
Balfour JA; Faulds D
Drugs; 1992 Feb; 43(2):259-84. PubMed ID: 1372222
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis associated with terbinafine treatment.
Lowe G; Green C; Jennings P
BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524
[No Abstract] [Full Text] [Related]
17. The treatment of dermatophytosis: safety considerations.
Smith EB
J Am Acad Dermatol; 2000 Nov; 43(5 Suppl):S113-9. PubMed ID: 11044286
[No Abstract] [Full Text] [Related]
18. Preclinical evaluation of terbinafine in vivo.
Mieth H; Petranyi G
Clin Exp Dermatol; 1989 Mar; 14(2):104-7. PubMed ID: 2598485
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis.
Kagawa S
Clin Exp Dermatol; 1989 Mar; 14(2):114-5. PubMed ID: 2689013
[No Abstract] [Full Text] [Related]
20. [Toxic hepatitis caused by ketoconazole].
Ned Tijdschr Geneeskd; 1983 Jun; 127(25):1114-5. PubMed ID: 6308481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
